OPENING OF BANKRUPTCY

Oncomfort

Financial year 2021 · closed on 31/12/2021
Net result
-1,6 M €
-38.5% YoY
Gross margin
-490,8 k €
+39.5% YoY
Equity
4,1 M €
+657.8% YoY

Company — Opening of bankruptcy.

What does Oncomfort do?

Oncomfort is a Public limited company incorporated in 2017. Its main activity is: Computer programming activities. Its registered office is in Wavre.

Legal situation
Opening of bankruptcy
BCE/KBO no. / VAT
BE 0674.419.521
Incorporation
11/04/2017
Legal form
Public limited company
Registered office
Avenue Einstein 16 box 12
1300 Wavre · WallonieSee on map
Contributed capital
7 988 711,80 €
Latest accounts
31/12/2021
Joint committees (3)
  • 100
  • 200
  • 218
Signals
Solid equityGood liquidityHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202120192018
Income statement
Gross margin-490,8 k €-811 k €-963,7 k €
EBITDA-1,3 M €-1,1 M €-1,3 M €
Operating result-1,6 M €-1,1 M €-1,5 M €
Net result-1,6 M €-1,2 M €-1,5 M €
Balance sheet
Equity4,1 M €-736,3 k €420 k €
Total assets5,3 M €1,5 M €977,6 k €
Cash2,9 M €1,1 M €734,1 k €
Debts656,1 k €2,1 M €416,2 k €
Other
Workforce4,0 ETP2,7 ETP
Governance

Board of directors

Seen on filing of 31/12/2021 · 6 active · 7 ended

Active mandates

TRANSFORM MEDICAL GMBH

Director · since 15 décembre 2021 · until 07 juin 2027

Represented by Kar SCHWEITZER

Active
CREDIT MUTUEL INNOVATION

Director · since 08 septembre 2020 · until 02 juin 2026

Represented by Delphine CARDI

Active
DEBIOPHARM INNOVATION FUND

Director · since 08 septembre 2020 · until 02 juin 2026

Represented by Tanja Dowe

Active
ARIOM

Managing director · since 01 octobre 2018 · until 04 mai 2022 · 0808.233.593

Represented by Mario HUYGHE

Active
Jérôme MAJOIE

Director · since 26 septembre 2018 · until 04 juin 2024

Active
Diane Jooris

Director · since 11 avril 2017 · until 07 juin 2022

Active

Ended mandates

CREDIT MUTUEL INNOVATION

Director · since 08 septembre 2020 · until 02 juin 2026 · 0756.981.070

Represented by Delphine CARDI

Ended
DEBIOPHARM INNOVATION FUND

Director · since 08 septembre 2020 · until 02 juin 2026 · 0756.981.466

Represented by Tanja DOWE

Ended
ARIOM

Managing director · since 01 octobre 2018 · until 04 juin 2024 · 0808.233.593

Represented by Mario Huyghe

Ended
ARIOM

Managing director · since 01 octobre 2018 · until 04 juin 2024 · 0808.233.593

Represented by Mario HUYGHE

Ended
At this address

Other companies at this address

CompanyCBE no.
CECAMAActive
0888.953.827
0536.459.686
MOVING PEOPLEActive
0873.678.208
Annual accounts

Full financial information

2021202020192018
Type of accountMicro modelMicro modelAbridged modelAbridged model
Start of the financial year01/01/202101/01/202001/01/201907/04/2017
Closing of the financial year31/12/202131/12/202031/12/201931/12/2018
Length of the financial year12 months12 months12 months21 months
Filing date05/09/202230/06/202102/06/202021/06/2019
General meeting22/06/202207/06/202104/05/202004/06/2019
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

4 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202122/06/202205/09/2022FrenchPDF
Micro model31/12/202007/06/202130/06/2021FrenchPDF
Abridged model31/12/201904/05/202002/06/2020FrenchPDF
Abridged model31/12/201804/06/201921/06/2019FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2021 · 6 active · 7 ended

Active mandates

TRANSFORM MEDICAL GMBH

Director · since 15 décembre 2021 · until 07 juin 2027

Represented by Kar SCHWEITZER

Active
CREDIT MUTUEL INNOVATION

Director · since 08 septembre 2020 · until 02 juin 2026

Represented by Delphine CARDI

Active
DEBIOPHARM INNOVATION FUND

Director · since 08 septembre 2020 · until 02 juin 2026

Represented by Tanja Dowe

Active
ARIOM

Managing director · since 01 octobre 2018 · until 04 mai 2022 · 0808.233.593

Represented by Mario HUYGHE

Active
Jérôme MAJOIE

Director · since 26 septembre 2018 · until 04 juin 2024

Active
Diane Jooris

Director · since 11 avril 2017 · until 07 juin 2022

Active

Ended mandates

CREDIT MUTUEL INNOVATION

Director · since 08 septembre 2020 · until 02 juin 2026 · 0756.981.070

Represented by Delphine CARDI

Ended
DEBIOPHARM INNOVATION FUND

Director · since 08 septembre 2020 · until 02 juin 2026 · 0756.981.466

Represented by Tanja DOWE

Ended
ARIOM

Managing director · since 01 octobre 2018 · until 04 juin 2024 · 0808.233.593

Represented by Mario Huyghe

Ended
ARIOM

Managing director · since 01 octobre 2018 · until 04 juin 2024 · 0808.233.593

Represented by Mario HUYGHE

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates12/12/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates25/10/2022
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates26/09/2022
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates17/06/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/03/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates12/11/2020
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Capital / shares05/11/2020
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates20/05/2020
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2021
    Annual accounts 2021-1,6 M €
  2. 2019
    Annual accounts 2019-1,2 M €
  3. 2018
    Annual accounts 2018-1,5 M €
  4. 11/04/2017
    IncorporationPublic limited company